3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Tumor-Agnostic
4
Gynecologic
2
Breast
2
Thoracic
1
Sarcoma
1
Head & Neck
1
Genitourinary
1
Gastrointestinal
1
Dermatologic
1
CNS
1
Conditions
Sarcoma
12
Osteosarcoma
9
Rhabdomyosarcoma
7
Neuroblastoma
7
Wilms Tumor
6
Rhabdoid Tumor
6
Lymphoma, Non-Hodgkin
6
Hepatoblastoma
6
Sarcoma, Ewing
5
Neuroectodermal Tumors, Primitive, Peripheral
5
Medulloblastoma
5
Histiocytosis, Langerhans-Cell
5
Glioma
5
Ependymoma
5
Central Nervous System Neoplasms
4
Liposarcoma
3
Carcinosarcoma
3
Sarcoma, Synovial
2
Ovarian Neoplasms
2
Neurofibrosarcoma
2
Melanoma
2
Leiomyosarcoma
2
Histiocytoma, Malignant Fibrous
2
Gliosarcoma
2
Glioblastoma
2
Endometrial Neoplasms
2
Desmoid Tumors
2
Carcinoma, Hepatocellular
2
Xanthogranuloma, Juvenile
1
Uterine Cervical Neoplasms
1
Interventions
pembrolizumab
11
Gemcitabine
10
Doxorubicin
10
Cyclophosphamide
9
Specimen Handling
8
Nivolumab
8
Ibandronic Acid
8
pazopanib
7
Radiosurgery
6
Magnetic Resonance Spectroscopy
6
Imatinib Mesylate
6
Biopsy
6
Bevacizumab
6
Irinotecan
5
regorafenib
4
Zoledronic Acid
4
Ipilimumab
4
Ifosfamide
4
Fluorouracil
4
Docetaxel
4
Cetuximab
4
sargramostim
3
conatumumab
3
cemiplimab
3
Sunitinib
3
Radiation
3
Paclitaxel
3
Leucovorin
3
Cryosurgery
3
Cisplatin
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Neoplasm Metastasis
×
X-Rays
×
Sarcoma
×
Clear all
NCT05269381
2026-03-12
PNeoVCA
Mayo Clinic
Phase 1/2
Recruiting
132 enrolled